Package 83107-003-15

Brand: zanaflex

Generic: tizanidine hydrochloride
NDC Package

Package Facts

Identity

Package NDC 83107-003-15
Digits Only 8310700315
Product NDC 83107-003
Product ID 83107-003_476ae6e6-0732-af36-e063-6394a90a7c02
Description

150 CAPSULE in 1 BOTTLE (83107-003-15)

Marketing

Marketing Status
Marketed Since 2018-08-01
Brand zanaflex
Generic tizanidine hydrochloride
Sample Package No

Linked Drug Pages (1)

Zanaflex ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "476ae6e6-0732-af36-e063-6394a90a7c02", "openfda": {"upc": ["0383107004158"], "unii": ["B53E3NMY5C"], "rxcui": ["153735", "313413", "485484", "485485", "485486", "580267", "583165", "583211"], "spl_set_id": ["60c27d35-7349-4fc6-86ad-70fffdbe3e08"], "manufacturer_name": ["Legacy Pharma USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE in 1 BOTTLE (83107-003-15)", "package_ndc": "83107-003-15", "marketing_start_date": "20180801"}], "brand_name": "Zanaflex", "product_id": "83107-003_476ae6e6-0732-af36-e063-6394a90a7c02", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "83107-003", "generic_name": "tizanidine hydrochloride", "labeler_name": "Legacy Pharma USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zanaflex", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "6 mg/1"}], "application_number": "NDA021447", "marketing_category": "NDA", "marketing_start_date": "20180801", "listing_expiration_date": "20271231"}